ADALIMUMAB
adalimumab 20 mg/0.4 mL injection, 0.4 mL syringe
ADALIMUMAB (12349Y)
12349Y
Manner of administration:Injection
Restriction 17713
Indication: Severe active juvenile idiopathic arthritis
Treatment phase: Continuing treatment
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 2 | Max qty units: 2 | # of repeats: 5 | DPMQ: $576.38 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
|
|
|||||